Skip to content
lifestyle.lincolnlabs.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Indivior Pharmaceuticals Inc.
National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder
March 17, 2026
Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering
March 12, 2026
Indivior Announces Proposed Convertible Senior Notes Offering
March 12, 2026
New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder
March 11, 2026
Indivior to Participate in Upcoming Investor Conferences
February 24, 2026
←
Previous Page
1
2